Volume 64, Issue 4, October 2023
Guidelines
European guidelines for the surgical management of pure ground-glass opacities and part-solid nodules: Task Force of the European Association of Cardio-Thoracic Surgery and the European Society of Thoracic Surgeons
Position Statement
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer
Lung cancer screening with low radiation dose computed tomography commonly detects incidental findings. This collaborative statement reviews the evidence and how this informs a clinically effective approach to these findings. https://bit.ly/3qlrlD3
Thoracic
Postoperative hormonal therapies reduce the recurrence of thoracic endometriosis-related pneumothorax
Thoracic endometriosis-related pneumothorax (TERP) is caused by endometrial tissues reaching the pleural cavity through unknown mechanisms.
Changes in pulmonary function in lung cancer patients after segmentectomy or lobectomy: a retrospective, non-intervention, observation study
Lung cancer is the leading cause of cancer-related mortality worldwide [1].
The role of the diagnostic wedge resection in the era of segmentectomy
Congenital
Long-term follow-up of atrioventricular valve function in Fontan patients: effect of atrioventricular valve surgery
The outcome of single ventricle palliation with the Fontan circulation is strongly compromised by atrioventricular valve regurgitation (AVVR).
Invited commentary to: Long-term follow-up of atrioventricular valve function in Fontan patients: effect of atrioventricular valve surgery
Congenital
Mid- and long-term outcomes after surgical correction of subaortic stenosis: a 27-year experience
Subaortic stenosis (SAS) represents a rare congenital heart defect accounting for 1–2% of all congenital cardiac anomalies [1].
Subaortic stenosis and recurrence: what we can influence and what nature decides
CardioCel® for repair of congenital heart defects: nationwide results of over 1000 implants
A variety of biomaterials including autologous pericardium are available for use as patches for the repair of congenital heart defects (CHD).
Experimental
Intravenous infusion of cardiac progenitor cells in animal models of single ventricular physiology
Stem cell therapies have recently been shown to be feasible and safe interventions for treating patients with congenital heart diseases, such as dilated cardiomyopathy and single-ventricle lesions [1, 2].
TX & MCS
Characterization of de novo malignancy after orthotopic heart transplantation: single-centre outcomes over 20 years
While remarkable advances have been made in durable mechanical support devices over the last decade, orthotopic heart transplantation (OHT) remains the preferred treatment for end-stage heart failure refractory to optimal medical therapy.
Consensus Statement
Preinterventional frailty assessment in patients scheduled for cardiac surgery or transcatheter aortic valve implantation: a consensus statement of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Preventive Cardiology (EAPC) of the European Society of Cardiology (ESC)
Conventional Aortic Surgery
The impact of malperfusion patterns in elderly patients undergoing surgery for acute type A aortic dissection
Acute type A aortic dissection (ATAAD) is a potentially lethal condition and requires urgent surgical repair [1].
Malperfusion in elderly with acute type A dissection: accepting the natural course of the disease
How to test adhesive strength: a biomechanical testing for aortic glue used in type a dissection repair
Gluing layers of dissected aortic tissue forms a fundamental component in the armamentarium of aortic surgeons.
Instructions for use: when and how to glue the dissected aorta
Outcomes of open repair for descending thoracic and thoracoabdominal aortic aneurysm in recent 10 years: experience of a high-volume centre in Korea
Although endovascular repair of a descending thoracic aortic aneurysm (TAA) or thoracoabdominal aortic aneurysm (TAAA) has been increasingly performed with better perioperative morbidity and mortality rates than those of open repair, the attained perioperative advantages are valid only during the early postoperative period [1–3].
Reoperative aortic root replacement for prosthetic aortic valve endocarditis: impact of aortic graft
The incidence of prosthetic valve endocarditis (PVE) of the aortic valve is increasing, and the surgical procedures to treat these conditions are complex, frequently requiring aortic root replacement (ARR) for associated root abscess.
Endovascular Aortic Surgery
Anatomical feasibility of a ‘semi-custom’ unibody single-branch endograft in previous zone 2 thoracic endovascular aortic repair
Most endografts currently available for thoracic endovascular aortic repair (TEVAR) require at least 20 mm of healthy aortic wall for an adequate proximal sealing according to their instructions for use, with European Association for Cardio-Thoracic Surgery (EACTS) recommending 25 mm [1].
A ‘semi-custom’ unibody single-branch endograft to preserve the left subclavian artery during thoracic endovascular aortic repair in zone 2: the answer to any question?
Endovascular arch repair of anastomotic aneurysm and pseudoaneurysm in patients after open repair of the ascending aorta and aortic arch: a case series
Anastomoses connecting robust prosthetic material with native tissue are known vulnerable locations, predominantly after previous repair of an acute aortic dissection [1].
General Adult Cardiac
A good operation is not enough, when it comes to frail patients
Trends and outcomes of concomitant aortic valve replacement and coronary artery bypass grafting in the UK and a survey of practices
Co-presentation with both valve and coronary disease is growing with the advancing age and clinical complexity of patients referred for cardiac surgery [1].
Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice
Direct oral anticoagulants (DOACs) have progressively replaced vitamin K antagonists (VKAs) in the treatment of venous thromboembolism and atrial fibrillation (AF).
Confounding adjustment in observational studies on cardiothoracic interventions: a systematic review of methodological practice
In cardiothoracic research, many studies aim for causal inference by comparing different surgical interventions or strategies.
Myocardial Revascularization
Physiopathology and improvement of the saphenous vein graft in coronary artery bypass graft
Catheter-based Valve Operations
Impact of different in vitro models on functional performance of the self-expanding transcatheter heart valve
Transcatheter aortic valve implantations are nowadays an established less invasive therapy for aortic valve stenosis, the most common valvular pathology in need of treatment [1–4].
Conventional Valve Operations
Outcomes of the Ross procedure in patients older versus younger than 50 years old
The Ross procedure is traditionally offered to young adult patients with expected long-term survival to avoid the potential of early bioprosthetic valve failure and the risk of long-term anticoagulation and shortened life expectancy with mechanical valves [1, 2].
Ross redux versus aortic valve repair
Neochordae implantation versus leaflet resection in mitral valve posterior leaflet prolapse and dilated left ventricle: a propensity score matching comparison with long-term follow-up
Surgical mitral valve (MV) repair represents the treatment of choice to address severe degenerative mitral regurgitation (MR).
Long-term proof of efficiency for respect versus resect techniques in mitral valve repair?
Neurological outcomes in minimally invasive mitral valve surgery: risk factors analysis from the Mini-Mitral International Registry
Neurological injury is a devastating complication after cardiovascular surgery.